What to do next for a patient with persistent left upper quadrant abdominal pain despite improved liver function tests (LFTs) and slightly better stools after treatment with rifaximin (Xifaxan) 550 and mebeverine (Colofac) 135?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Persistent Left Upper Quadrant Pain After Rifaximin and Mebeverine Treatment

Immediate Next Step: Obtain CT Abdomen/Pelvis with IV Contrast

You should immediately order CT abdomen and pelvis with IV contrast to evaluate for structural pathology causing persistent left upper quadrant pain, as this is the preferred imaging modality with excellent diagnostic accuracy and can alter diagnosis in nearly half of cases. 1

Rationale for CT Imaging

  • CT abdomen/pelvis with IV contrast is rated 8/9 (usually appropriate) by the American College of Radiology for left upper quadrant pain evaluation and provides comprehensive assessment of splenic pathology, pancreatic disease, gastric abnormalities, and vascular conditions 1

  • The American College of Radiology emphasizes that CT alters diagnosis in approximately 49% of patients with nonlocalized abdominal pain and should not be dismissed without imaging when clinical suspicion exists 1

  • CT has moderate sensitivity (69%) but excellent specificity (100%) for detecting acute abdominal abnormalities in left upper quadrant pain, with positive predictive value of 100% 2

  • Plain radiography and ultrasound have very limited diagnostic value for left upper quadrant pain due to overlying bowel gas and rib shadowing 1

Critical Differential Diagnoses to Exclude

Life-Threatening Conditions Requiring Urgent Evaluation

  • Perforated viscus or intra-abdominal abscess: If fever or leukocytosis is present, CT will detect free intraperitoneal air (92% positive predictive value for perforation) or fluid with peritoneal enhancement suggesting peritonitis 1

  • Atypical appendicitis with malrotation: Left upper quadrant appendicitis can occur with congenital intestinal malrotation and requires high index of suspicion, as CT will reveal both the malrotation and inflamed appendix 1, 3

  • Mesenteric ischemia: If the patient has postprandial pain with weight loss and atherosclerotic risk factors, CT angiography should be obtained to evaluate for chronic mesenteric ischemia 1

Common Structural Causes

  • Splenic pathology, pancreatic disease (including pancreatitis), gastric abnormalities, renal pathology (nephrolithiasis or pyelonephritis), and vascular conditions can all present as left upper quadrant pain 1

If CT is Normal: Functional Dyspepsia Management Algorithm

Step 1: Test and Treat H. pylori

  • The American Gastroenterological Association recommends testing all patients with persistent dyspepsia for H. pylori using validated non-invasive testing and providing eradication therapy if positive 4

  • If H. pylori is positive, treat with appropriate antibiotic regimen; if negative or symptoms persist after eradication, proceed to Step 2 4

Step 2: Initiate Proton Pump Inhibitor Therapy

  • Prescribe a PPI at the lowest effective dose for 4-8 weeks as first-line treatment for functional dyspepsia 5, 4

  • The American Gastroenterological Association recommends empirical acid suppression therapy combined with dietary modifications for adolescents and adults with postprandial vomiting and upper abdominal pain 5

  • Dietary modifications should include avoiding trigger foods like coffee, which can reduce chemical irritation of the duodenal mucosa and alter gastric emptying 5

Step 3: Second-Line Treatment for PPI Non-Responders

  • The American College of Gastroenterology recommends low-dose tricyclic antidepressants (TCAs) as the most effective second-line treatment, particularly for epigastric pain syndrome 4

  • Start with amitriptyline 10 mg daily at bedtime, slowly titrate up to 30-50 mg as tolerated 4

  • TCAs modulate pain perception at the gut-brain axis level and are more effective than continuing PPI therapy alone 4

Red Flags Requiring Urgent Re-evaluation

  • Immediately escalate care if the patient develops weight loss, inability to maintain adequate nutrition, severe or progressive pain, fever with localized pain, or signs of dehydration 5

  • Patients with alarm symptoms such as dysphagia, persistent vomiting, gastrointestinal bleeding, or regular NSAID use should undergo prompt upper endoscopy 4

  • Rebound tenderness with abdominal distension occurs in 82.5% of patients with peritonitis and mandates immediate emergency surgical evaluation 1

Role of Rifaximin in This Clinical Context

  • Rifaximin 550 mg twice daily is FDA-approved for IBS with diarrhea (IBS-D) and showed 40.8% response rate for global IBS symptom improvement versus 31.7% with placebo 6, 7

  • Rifaximin is NOT indicated for isolated left upper quadrant pain or functional dyspepsia without diarrhea-predominant IBS 6, 7

  • The fact that LFTs improved suggests rifaximin may have addressed small intestinal bacterial overgrowth (SIBO) or hepatic encephalopathy, but persistent pain indicates a different underlying pathology requiring structural evaluation 7, 8

Common Pitfalls to Avoid

  • Do not withhold symptomatic treatment while pursuing extensive diagnostic workup—empirical treatment can be initiated after excluding serious pathology with CT imaging 5

  • Do not ignore psychosocial factors, as chronic stress can strongly predict persistence of functional gastrointestinal symptoms, and providing education and reassurance establishes an effective therapeutic relationship 5

  • Avoid opioids and surgery in patients with severe or refractory functional dyspepsia to minimize iatrogenic harm 4

  • Do not implement overly restrictive diets that may lead to malnutrition or abnormal eating behaviors; regular exercise and lifestyle changes without highly restrictive diets should be implemented 5

Management of Refractory Symptoms

  • If symptoms persist despite PPI and TCA therapy, consider combination therapy with dual H1 and H2 receptor antagonists, or TCA combined with SSRI 1

  • Refer to gastroenterology for consideration of endoscopy, advanced prokinetics, or behavioral interventions for patients with refractory symptoms 1

  • The American Gastroenterological Association recommends referring patients with severe or refractory symptoms to a multidisciplinary team including primary care physicians, dietitians, gastroenterologists, and psychologists 4

References

Guideline

Evaluation of Left Upper Quadrant Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Dyspepsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Functional Dyspepsia in Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Use of rifaximin in gastrointestinal and liver diseases.

World journal of gastroenterology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.